<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00798993</url>
  </required_header>
  <id_info>
    <org_study_id>SCGH25OHD2008</org_study_id>
    <nct_id>NCT00798993</nct_id>
  </id_info>
  <brief_title>Effect of 25-hydroxyvitamin D and a Structured Exercise Program on Dialysis Patients</brief_title>
  <official_title>The Effect of 25-hydroxyvitamin D Supplementation and a Structured Exercise Program on Exercise Capacity and Quality of Life in Dialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sir Charles Gairdner Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sir Charles Gairdner Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to examine the effect of 25 hydroxyvitamin D supplementation and a structured
      exercise program on the exercise capacity and quality of life of haemodialysis patients with
      25 hydroxyvitamin D insufficiency.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Exercise capacity - modified shuttle walk test</measure>
    <time_frame>Basesline, 3 &amp; 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life with KDQOL</measure>
    <time_frame>Baseline, 3 &amp; 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quadriceps Strength</measure>
    <time_frame>Baseline, 3 &amp; 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum phosphate</measure>
    <time_frame>baselibe, 3 &amp; 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feeling thermometer</measure>
    <time_frame>Baseline, 3 &amp; 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Timed up and go</measure>
    <time_frame>baseline, 3 &amp; 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Falls</measure>
    <time_frame>continuous</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulse wave velocity</measure>
    <time_frame>baseline, 3 &amp; 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bioimpedance</measure>
    <time_frame>Baseline, 3 &amp; 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>End Stage Kidney Disease</condition>
  <arm_group>
    <arm_group_label>Structured exercise program</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will be randomised at 3 months into either this group or the comparator of usual exercise.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cholecalciferol 2000U per day will be given to all participants for the duration of the study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual exercise</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants randomised to this arm, at 3 months, will continue on their usual exercise routine</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Structured Exercise program</intervention_name>
    <description>30 minutes on an exercise bicycle during every dialysis</description>
    <arm_group_label>Structured exercise program</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cholecalciferol (25-Hydroxyvitamin D)</intervention_name>
    <description>Cholecalciferol 2000U per day will be given for duration of study to all participants</description>
    <arm_group_label>Vitamin D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual exercise</intervention_name>
    <description>Participants randomised to this arm at 3 months will continue on their usual exercise routine for the remaining 3 months</description>
    <arm_group_label>Usual exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Stable on dialysis for at least 3 months

          2. Able to obtain informed consent

          3. Medically stable

          4. Dialysis adequacy at target for small solute clearance (ie Kt/V&gt;1.2 or Urea reduction
             ratio&gt;65%)

          5. Serum 25-hydroxyvitamin D levels less than 75nmol/L at baseline

        Exclusion Criteria:

          1. Limb Amputation

          2. Impaired cognition

          3. Impaired vision

          4. Haemoglobin concentration &lt; 110g/L

          5. Change in Erythropoiesis stimulating agent dose over the last 2 months

          6. Unable or unwilling to comply with exercise program
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ben Bull</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sir Charles Gairdner Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Neil Boudville</last_name>
    <role>Study Director</role>
    <affiliation>Sir Charles Gairdner Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sir Charles Gairdner Hospital</name>
      <address>
        <city>Perth</city>
        <state>Western Australia</state>
        <zip>6009</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2008</study_first_submitted>
  <study_first_submitted_qc>November 26, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 27, 2008</study_first_posted>
  <last_update_submitted>June 6, 2013</last_update_submitted>
  <last_update_submitted_qc>June 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 10, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sir Charles Gairdner Hospital</investigator_affiliation>
    <investigator_full_name>Neil Boudville</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Chronic kidney failure</keyword>
  <keyword>25 hydroxyvitamin D</keyword>
  <keyword>falls</keyword>
  <keyword>exercise</keyword>
  <keyword>quadriceps strength</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Hydroxycholecalciferols</mesh_term>
    <mesh_term>Calcifediol</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

